Your session is about to expire
← Back to Search
Multi-Level Intervention for Colorectal Cancer Screening (ACCSIS Trial)
N/A
Recruiting
Led By Mark B Dignan, PhD
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 50-74
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
ACCSIS Trial Summary
This trial will test whether a multi-level intervention can increase colorectal cancer screening rates in 12 counties in Appalachian Kentucky and Ohio.
Who is the study for?
This trial is for residents aged 50-74 in certain Appalachian counties of Kentucky and Ohio, regardless of their race, sex, or gender. It aims to help increase colorectal cancer screening rates in these communities.Check my eligibility
What is being tested?
The study tests a multi-level intervention designed to boost colorectal cancer screenings by involving clinics, providers, patients, and the community. Half the counties start early while the other half begin later to compare effectiveness.See study design
What are the potential side effects?
Since this trial focuses on increasing screening rather than testing a medical product or drug, it does not have direct side effects like those associated with medications.
ACCSIS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 50 and 74 years old.
ACCSIS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CRC screening - clinic level
Secondary outcome measures
CRC screening - community level
ACCSIS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Multi-level InterventionExperimental Treatment1 Intervention
Receives the project intervention first
Group II: Delayed Multi-level InterventionActive Control1 Intervention
Offered the intervention later in the project
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,918,408 Total Patients Enrolled
University of KentuckyLead Sponsor
185 Previous Clinical Trials
220,402 Total Patients Enrolled
Ohio State UniversityOTHER
829 Previous Clinical Trials
499,503 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My race, sex, or gender does not limit my participation.My eligibility is not affected by my gender, race, or ethnicity.I am between 50 and 74 years old.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Delayed Multi-level Intervention
- Group 2: Multi-level Intervention
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research trial open to individuals under the age of 55?
"This trial is welcoming patients aged between 50 and 74 years old."
Answered by AI
Are there any available enrollments for this clinical research?
"According to clinicaltrials.gov, this research endeavor is currently enrolling participants. Initial posting was on August 19th 2020 and the trial has since been revised on May 16th 2022."
Answered by AI
Am I a plausible participant in this experiment?
"Candidates aged 50 to 74 with colorectal carcinoma are encouraged to apply for this clinical trial, as 6240 places need to be filled."
Answered by AI
How many participants have registered for the research project?
"Verified, the clinicaltrials.gov portal indicates that this trial is actively seeking enrolment and has been since August 19th 2020. The study seeks to enlist 6240 participants at 2 unique medical centers before its conclusion on May 16 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger